SEC Form 4 · accession 0001388410-18-000005
PARALLAX HEALTH SCIENCES, INC. · PRLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul R Arena
Officer — PRESIDENT · Director
Period of report
Apr 6, 2018
Accepted (ET)
Apr 19, 2018 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388410
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK (RESTRICTED)F1,F2 | Apr 6, 2018 | P | 2,500,000 | $0.001 | A | 5,000,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Granted pursuant to Employment Agreement dated July 1, 2017.
- F2Total restricted stock grant 10,000,000 common shares, of which a total of 5,000,000 have been issued, 2,500,000 will vest July 1, 2019 and 2,500,000 will vest upon positive earnings.